Stockscreener 앱 받기
0.2408
5.46%
-0.0139
전일 마감가:
$0.2547
열려 있는:
$0.258
하루 거래량:
758.58K
Relative Volume:
0.53
시가총액:
$12.01M
수익:
-
순이익/손실:
$-60.11M
주가수익비율:
-0.0554
EPS:
-4.347
순현금흐름:
$-12.04M
1주 성능:
-23.36%
1개월 성능:
-18.65%
6개월 성능:
-77.91%
1년 성능:
-68.63%
1일 변동 폭
$0.24
$0.2759
1주일 범위
$0.24
$0.31
52주 변동 폭
$0.1772
$1.45
AEON Biopharma Inc. Stock (AEON) Company Profile
명칭
AEON Biopharma Inc.
전화
(949) 354-6499
주소
5 Park Plaza, Suite 1750, Irvine
Compare AEON vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.2408 | 9.63M | 0 | -60.11M | -12.04M | -4.347 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-18 | 개시 | H.C. Wainwright | Buy |
AEON Biopharma Inc. 주식(AEON)의 최신 뉴스
Aeon Biopharma director Timothy Lynch buys $243,455 in stock - Investing.com
Timothy Lynch (NASDAQ: AEON) owns 13% and holds blocked warrants - Stock Titan
AEON Reports New Data on Botox Biosimilar - Orange County Business Journal
Lake Street Maintains AEON Biopharma(AEON.US) With Buy Rating, Maintains Target Price $1 - Moomoo
AEON Flat on BOTOX Developments - Baystreet.ca
META_TITLE_QUOTE - Yahoo Finance
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX® - The Manila Times
AEON Biopharma (AEON) Steadies at $0.28 as Key Support HoldsVolume Gap - vinanet.vn
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution - Investing.com
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution By Investing.com - Investing.com UK
AEON Biopharma (AEON) Holds Above $0.27 Support as Shares Edge Up 1.66%Extension Target - vinanet.vn
AEON Q4 2025 Earnings: Wider-than-Expected Loss of -$0.42 per Share as Revenue Remains Absent - vinanet.vn
H.C. Wainwright Maintains AEON Biopharma(AEON.US) With Buy Rating, Cuts Target Price to $1.2 - Moomoo
AEON Biopharma Q2 EPS $(0.02) beats $(0.12) estimate - scanx.trade
AEON Biopharma Reports Q2 Results, Advances ABP-450 Program - TipRanks
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma Q2 net loss narrows on warrant gain; cash runway extended - TradingView
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
AEON BIOPHARMA INC Q2 EBIT USD -5.919 MILLION - Moomoo
Aeon Biopharma Inc (AEON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aeon Biopharma Inc (AEON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AEON Biopharma Regains NYSE American Listing Compliance - TipRanks
AEON Biopharma Regains NYSE American Compliance After Completing Public Offering - Quiver Quantitative
AEON Biopharma (NYSE American: AEON) lifts .BC indicator after $13.6M equity raise - Stock Titan
AEON Biopharma Raises About $13.6M Net, Regains Listing Compliance - Stock Titan
AEON Q4 2025 Earnings: Wider Loss of -$0.42 Per Share Overshadowed by 14.81% Stock SurgeHealthcare Earnings Report - vinanet.vn
AEON Q4 2025 Earnings: Deep EPS Miss Overshadowed by 14.81% Share RallyPeak Earnings Alert - vinanet.vn
AEON Biopharma, Inc. Revenue Breakdown – AMEX:AEON - TradingView
Aeon Biopharma Inc (AEON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AEON|Aeon Biopharma Inc|Price:0.257|Chg%:+0.006 - TradingKey
Aeon Biopharma Inc (AEON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aeon Biopharma Inc (AEON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aeon Biopharma Inc (AEON) Income Statement - TradingKey
Aeon Biopharma Inc (AEON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bitget Launchpool adds AEON (AEON) with 1.1M in Token Rewards - GlobeNewswire Inc.
Aeon Biopharma Inc (AEON) Balance Sheet - TradingKey
Aeon Biopharma Inc (AEON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aeon Biopharma Inc (AEON) Cash Flow - TradingKey
AEON Biopharma, Inc. Revenue Breakdown – BOATS:AEON - TradingView
Aeon Biopharma Inc (AEON) Institutional Confidence - TradingKey
Aeon Biopharma Inc (AEON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AEON|Aeon Biopharma Inc|Price:0.228|Chg%:-0.023 - TradingKey
AEON Biopharma boosts liquidity with additional share sale - The Globe and Mail
AEON Biopharma says underwriters fully exercise milestone warrant over-allotment option for 6,403,290 shares - Bitget
Stonepine Capital group discloses 9.9% AEON Biopharma (AEON) ownership via stock and warrants - Stock Titan
AEON Q4 2025 Earnings: Significant EPS Miss as Biotech Continues Development PhaseProfit Growth Outlook - vinanet.vn
AEON Biopharma Inc. (AEON) Hovers Near Support as Bearish Pressure PersistsMutual Fund Flow - dars.gov.et
NFA- today's 8K - Moomoo
AEON Biopharma (NYSE American: AEON) prices $13.75M stock and milestone warrant sale - Stock Titan
AEON Biopharma (NYSE American: AEON) sells stock and milestone-tied warrants - Stock Titan
AEON BiopharmaOffering Includes 42.69 Mln - Moomoo
AEON Biopharma Inc. (AEON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):